IRWD FY 2019 Earnings — Ironwood Pharmaceuticals, Inc. Revenue & Financial Results | Market Cap Arena

IRWDIronwood Pharmaceuticals, Inc.

$603M

FY 2019 Earnings

Healthcare Drug Manufacturers - Specialty & Generic

Income Statement

Revenue

$428M+23.6% YoY

Gross Profit

$293M68.4% margin

Operating Income

$120M28.0% margin

Net Income

$22M5.0% margin

EPS (Diluted)

$-0.10

Cash Flow

Operating Cash Flow

$11M

Free Cash Flow

$4M

Stock-Based Comp.

$31M

Balance Sheet

Total Assets

$403M

Total Liabilities

$496M

Stockholders' Equity

-$93M

Cash & Equivalents

$177M

Year-over-Year Comparison

Metric	Current	Year Ago	Change
Revenue	$428M	$347M	+23.6%
Gross Profit	$293M	$314M	-6.6%
Operating Income	$120M	-$239M	+150.3%
Net Income	$22M	-$282M	+107.6%